Latest filing published 05 May 2026 for AMGEN INC, €196k.
Filing timeline
BuySaleInsider track record
Esteban Santos: trading record in brief
Esteban Santos, EVP, Operations at Amgen Inc, has filed 68 times between February 1, 2017 and May 5, 2026, at a strikingly stable pace: 6 to 8 filings a year. Equity pay makes up most of it, with 62 grants and 3 option exercises.
The 3 sales in the record weigh EUR 20.0 million, with a median of EUR 7,794,394. Two of them are from February 26, 2026 (EUR 9,787,032 and EUR 7,794,394) and the third from February 19, 2025 (EUR 2,441,469). No purchase is in the record. Eight filings fall in the last 12 months, 2 of them sales. Filings are published a median of 2 days after the trade, across 68 dated filings.
Within 30 days of colleagues' trades at Amgen Inc, Santos has 2 trades with Matthew C. Busch and 1 with each of David M. Reese, Derek Miller, Jonathan P. Graham and Murdo Gordon, all in the same direction.
Companies and markets linked to Esteban Santos
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 697 shares@ US$329.820.0001% mcap1.4% of flowCommon StockSEC:0000318154-26-000068:0
- 641 shares@ US$329.820.0001% mcap1.3% of flowCommon StockSEC:0000318154-26-000068:1
- 5,621 shares@ US$366.2112.5% of flowCommon StockSEC:0000318154-26-000033:0
- 11,259 shares0Common StockSEC:0000318154-26-000022:0
- 30,501 shares@ US$379.1222.5% of flowCommon StockSEC:0000318154-26-000012:1
- 24,291 shares@ US$177.468.4% of flowCommon StockSEC:0000318154-26-000012:2
- 24,291 shares@ US$379.1217.9% of flowCommon StockSEC:0000318154-26-000012:3
- 30,501 shares@ US$162.6029.2% of flowCommon StockSEC:0000318154-26-000012:0
- 3,327 shares0Common StockSEC:0001127602-25-013787:0
- 655 shares@ US$283.781.1% of flowCommon StockSEC:0001127602-25-013534:0
- 621 shares@ US$283.781.1% of flowCommon StockSEC:0001127602-25-013534:1
- 759 shares@ US$288.561.3% of flowCommon StockSEC:0001127602-25-013287:0
- 3,393 shares@ US$313.716.8% of flowCommon StockSEC:0001127602-25-010061:0
- 6,792 shares0Common StockSEC:0001127602-25-008429:0
- 8,711 shares@ US$292.845.6% of flowCommon StockSEC:0001127602-25-006284:1
- 8,711 shares@ US$156.359.1% of flowCommon StockSEC:0001127602-25-006284:0
- 2,997 shares@ US$300.305.8% of flowCommon StockSEC:0001127602-24-014859:0
- 617 shares@ US$311.291.2% of flowCommon StockSEC:0001127602-24-014513:0
- 606 shares@ US$277.371.1% of flowCommon StockSEC:0001127602-24-014197:0
- 683 shares@ US$276.381.2% of flowCommon StockSEC:0001127602-24-013814:0
- 6,137 shares@ US$268.8710.6% of flowCommon StockSEC:0001127602-24-010859:0
- 12,278 shares0Common StockSEC:0001127602-24-009249:0
- 579 shares@ US$231.890.8% of flowCommon StockSEC:0001127602-23-015052:0
- 716 shares@ US$235.970.4% of flowCommon StockSEC:0001127602-23-014613:1
- 3,559 shares0Common StockSEC:0001127602-23-014613:0
25 of 68 declarations